[
  {
    "ts": null,
    "headline": "Trump's big beautiful bill: What the pharma industry is watching",
    "summary": "Pharmaceutical stocks, including Pfizer (PFE), Johnson & Johnson (JNJ), Abbvie (ABBV), Novo Nordisk (NVO), and Astrazeneca (AZN), are falling after President Trump said tariffs on the industry are coming \"very soon.\" Chris Meekins, managing director and Washington health policy research analyst at Raymond James, joins Market Domination to discuss potential tariffs and explain how President Trump's tax bill could affect the pharmaceutical industry. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
    "url": "https://finnhub.io/api/news?id=6248ba62415c0d98cf70db9a6829706b01cfd3a870c8f72a7fa03c8efc5898e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750194995,
      "headline": "Trump's big beautiful bill: What the pharma industry is watching",
      "id": 135340446,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pharmaceutical stocks, including Pfizer (PFE), Johnson & Johnson (JNJ), Abbvie (ABBV), Novo Nordisk (NVO), and Astrazeneca (AZN), are falling after President Trump said tariffs on the industry are coming \"very soon.\" Chris Meekins, managing director and Washington health policy research analyst at Raymond James, joins Market Domination to discuss potential tariffs and explain how President Trump's tax bill could affect the pharmaceutical industry. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
      "url": "https://finnhub.io/api/news?id=6248ba62415c0d98cf70db9a6829706b01cfd3a870c8f72a7fa03c8efc5898e5"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. stock outperforms competitors despite losses on the day",
    "summary": "Pfizer Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=e6d66dc532fcaac8d1dd7bd446b226d56277b6018228216a4550fd0ead44c932",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750178100,
      "headline": "Pfizer Inc. stock outperforms competitors despite losses on the day",
      "id": 135357018,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=e6d66dc532fcaac8d1dd7bd446b226d56277b6018228216a4550fd0ead44c932"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer : 2024 Impact Report",
    "summary": "2024 Impact Report ...",
    "url": "https://finnhub.io/api/news?id=ae4ee1b5656fb1c4ddbd7adc5d1914754360bb7ce4ca0263168f7a45bb0f0644",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750177566,
      "headline": "Pfizer : 2024 Impact Report",
      "id": 135339407,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "2024 Impact Report ...",
      "url": "https://finnhub.io/api/news?id=ae4ee1b5656fb1c4ddbd7adc5d1914754360bb7ce4ca0263168f7a45bb0f0644"
    }
  },
  {
    "ts": null,
    "headline": "AMD extends gains, solar stocks plummet, pharma stocks",
    "summary": "Wealth host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute. Advanced Micro Devices (AMD) stock extends its gains from Monday when Piper Sandler raised its price target for the company. Solar energy stocks, including Enphase (ENPH), First Solar (FSLR), and SolarEdge (SEDG), plummet as Senate Republicans consider phasing out clean energy tax credits by 2028. Pharmaceutical stocks, such as Eli Lilly (LLY), Pfizer (PFE), and Abbvie (ABBV), are under pressure as the Trump administration considers curbing direct-to-consumer drug advertising. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
    "url": "https://finnhub.io/api/news?id=90631f694600db52342c8cb957af406f7d9a2700e514e3f3adc13df2cf440585",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750173499,
      "headline": "AMD extends gains, solar stocks plummet, pharma stocks",
      "id": 135327762,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Wealth host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute. Advanced Micro Devices (AMD) stock extends its gains from Monday when Piper Sandler raised its price target for the company. Solar energy stocks, including Enphase (ENPH), First Solar (FSLR), and SolarEdge (SEDG), plummet as Senate Republicans consider phasing out clean energy tax credits by 2028. Pharmaceutical stocks, such as Eli Lilly (LLY), Pfizer (PFE), and Abbvie (ABBV), are under pressure as the Trump administration considers curbing direct-to-consumer drug advertising. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
      "url": "https://finnhub.io/api/news?id=90631f694600db52342c8cb957af406f7d9a2700e514e3f3adc13df2cf440585"
    }
  },
  {
    "ts": null,
    "headline": "Trump reportedly threatens pharma ads, disrupting $10B market",
    "summary": "The Trump administration is considering putting in place legal and financial hurdles that would reduce the number of pharmaceutical ads, according to reports from Bloomberg, citing sources close to the matter. Pharmaceutical companies represent over $10 billion of annual ad spend. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.",
    "url": "https://finnhub.io/api/news?id=043de4899df6e6a035e9d6c500a9348d7185d0ae39054accac2ff89db2c5c7e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750170730,
      "headline": "Trump reportedly threatens pharma ads, disrupting $10B market",
      "id": 135336666,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The Trump administration is considering putting in place legal and financial hurdles that would reduce the number of pharmaceutical ads, according to reports from Bloomberg, citing sources close to the matter. Pharmaceutical companies represent over $10 billion of annual ad spend. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.",
      "url": "https://finnhub.io/api/news?id=043de4899df6e6a035e9d6c500a9348d7185d0ae39054accac2ff89db2c5c7e7"
    }
  },
  {
    "ts": null,
    "headline": "RFK Jr. Plans Crackdown on Pharma Ads in Threat to $10 Billion Market",
    "summary": "(Bloomberg) -- The Trump administration is discussing policies that would make it harder and more expensive for pharmaceutical companies to advertise directly to patients, in a move that could disrupt more than $10 billion in annual ad spending.Most Read from BloombergSecurity Concerns Hit Some of the World’s ‘Most Livable Cities’As Part of a $45 Billion Push, ICE Prepares for a Vast Expansion of Detention SpaceAs American Architects Gather in Boston, Retrofits Are All the RageHow E-Scooters Con",
    "url": "https://finnhub.io/api/news?id=4f13bd1d807f814d194a94fbc1572d6fab61acd4f736c1a4a240b1ac0fe3a62d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750169552,
      "headline": "RFK Jr. Plans Crackdown on Pharma Ads in Threat to $10 Billion Market",
      "id": 135327459,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- The Trump administration is discussing policies that would make it harder and more expensive for pharmaceutical companies to advertise directly to patients, in a move that could disrupt more than $10 billion in annual ad spending.Most Read from BloombergSecurity Concerns Hit Some of the World’s ‘Most Livable Cities’As Part of a $45 Billion Push, ICE Prepares for a Vast Expansion of Detention SpaceAs American Architects Gather in Boston, Retrofits Are All the RageHow E-Scooters Con",
      "url": "https://finnhub.io/api/news?id=4f13bd1d807f814d194a94fbc1572d6fab61acd4f736c1a4a240b1ac0fe3a62d"
    }
  },
  {
    "ts": null,
    "headline": "Should Value Investors Buy Pfizer (PFE) Stock?",
    "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
    "url": "https://finnhub.io/api/news?id=16477971bb7c618140f1651f11d33257a67d7b9cd068c4414e943e8f76058605",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750167603,
      "headline": "Should Value Investors Buy Pfizer (PFE) Stock?",
      "id": 135336668,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
      "url": "https://finnhub.io/api/news?id=16477971bb7c618140f1651f11d33257a67d7b9cd068c4414e943e8f76058605"
    }
  },
  {
    "ts": null,
    "headline": "5 Low Price-to-Book Value Stocks That You Can Buy in June",
    "summary": "The P/B ratio helps to identify low-priced stocks with high growth prospects. USNA, CVS, PFE, STNE and PSFE are some such stocks.",
    "url": "https://finnhub.io/api/news?id=2990f9aabb057e329a6de8fce0bbf01e1cce7e3ac534574c5cab666d306b3d73",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750165320,
      "headline": "5 Low Price-to-Book Value Stocks That You Can Buy in June",
      "id": 135335830,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The P/B ratio helps to identify low-priced stocks with high growth prospects. USNA, CVS, PFE, STNE and PSFE are some such stocks.",
      "url": "https://finnhub.io/api/news?id=2990f9aabb057e329a6de8fce0bbf01e1cce7e3ac534574c5cab666d306b3d73"
    }
  },
  {
    "ts": null,
    "headline": "Why I Just Bought More of This Beaten-Down 7%-Yielding Dividend Stock",
    "summary": "Pfizer's negatives are fully baked into its share price.  The drugmaker's juicy dividend pays investors handsomely to wait for Pfizer to deliver on its potential.  Regardless of which you choose, Pfizer's (NYSE: PFE) share price has declined during the period.",
    "url": "https://finnhub.io/api/news?id=fc5c81f4bba1a253922cbab10db1c68e4268a770c68a5a9af75b2f3dca451881",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750150140,
      "headline": "Why I Just Bought More of This Beaten-Down 7%-Yielding Dividend Stock",
      "id": 135336670,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer's negatives are fully baked into its share price.  The drugmaker's juicy dividend pays investors handsomely to wait for Pfizer to deliver on its potential.  Regardless of which you choose, Pfizer's (NYSE: PFE) share price has declined during the period.",
      "url": "https://finnhub.io/api/news?id=fc5c81f4bba1a253922cbab10db1c68e4268a770c68a5a9af75b2f3dca451881"
    }
  }
]